How can Regulatory Authorities support accelerated approval of antibiotics addressing unmet needs?

1. Include antimicrobials targeting serious and life-threatening infections within the regulatory framework for accelerated approval pathways.
2. Improve capacity to deal with the complexity of AMR and advanced clinical trials.
3. Foster regulatory harmonization and reliance on other Regulatory Authorities.